Symbio Generrics India Private Limited - Company Profile

It is a pharma private limited company based in Bangalore South, Karnataka, India, established in 2011.
2011 Bangalore South, Karnataka, India Active
Last Updated:
Access Report
About Symbio Generrics India Private Limited

Symbio Generrics India Private Limited, a active private limited company, was established on 30 May 2011 in Bangalore South, Karnataka, India. Engaging in api manufacturers within the trade sector, it holds CIN: U74990KA2011PTC184231. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹3.10 Cr and a paid-up capital of ₹3.01 Cr.

It upholds a compliant status. Employing 161 professional, Its leadership includes Kannan Natraj Sharma (Director), Salim Sadiq Shaikh (Whole-Time Director), Akash Suresh Puranik (Managing Director). Past directors included Kannan Natraj Sharma, Lakshmi Reddy Devalla, Abhijit Govindrao Kale. It holds ₹268.03 Cr open charges and ₹22.92 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Symbio House, No-1215, 24Th Main,, 11Th Cross, Hsr Layout 1St Sector,, Bangalore South, Karnataka, 560102.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74990KA2011PTC184231

  • Registration Number

    184231

  • Incorporation Date

    30 May 2011

  • Authorized Capital

    ₹3.10 Cr

  • Paid-Up Capital

    ₹3.01 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.10 Cr
  • Paid Up Capital ₹ 3.01 Cr
  • Company Age 14 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 268.03 Cr
  • Satisfied Charges ₹ 22.92 Cr
  • Revenue Growth **** 7.64%
  • Profit Growth **** -52.56%
  • Ebitda **** -49.49%
  • Net Worth 62.24%
  • Total Assets **** 70.45%
Company report

Symbio Generrics India Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Symbio Generrics India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Symbio Generrics India Private Limited?
Current Directors
Name Designation Appointment Date Status
Kannan Natraj Sharma Director 19 Sep 2022 Current
Salim Sadiq Shaikh Whole-Time Director 30 May 2011 Current
Akash Suresh Puranik Managing Director 30 Sep 2017 Current
Deepak Komaregowda Nominee Director 30 Mar 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 26 Sep 2022 Past
Pramod Abcsdd Director 25 Nov 2019 Past
Pramod Abcsdd Director 17 Jan 2022 Past
Pramod Abcsdd Director 30 Mar 2022 Past
Pramod Abcsdd Nominee Director 04 Dec 2024 Past
Pramod Abcsdd Director 30 Mar 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Symbio Generrics India.

Symbio Generrics India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.64% increase. The company also saw a substantial fall in profitability, with a 52.56% decrease in profit. The company's net worth Soared by an impressive increase of 62.24%.

Symbio Generrics India revenue growth over time
Symbio Generrics India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 7.64%
*******
*******
*******
*******
Revenue from Operations
*******
 7.43%
*******
*******
*******
*******
Total Assets
*******
 70.45%
*******
*******
*******
*******
Profit or Loss
*******
 -52.56%
*******
*******
*******
*******
Net Worth
*******
 62.24%
*******
*******
*******
*******
EBITDA
*******
 -49.49%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Symbio Generrics India?

In 2023, Symbio Generrics India had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,680,250,000.00

Satisfied Charges

₹229,240,000.00

Charges Breakdown by Lending Institutions
  • Others : 142.65 Cr
  • Axis Bank Limited : 100.00 Cr
  • Citi Bank N.A. : 25.00 Cr
  • Hdfc Bank Limited : 0.38 Cr
Latest Charge Details
Date Lender Amount Status
11 Nov 2025 Others ₹15.00 Cr Open
27 Jun 2024 Others ₹12.00 Cr Open
14 Dec 2023 Citi Bank N.A. ₹25.00 Cr Open
11 Dec 2023 Axis Bank Limited ₹30.00 Cr Open
10 Jul 2023 Others ₹20.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Symbio Generrics India?

Symbio Generrics India has a workforce of 161 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Symbio Generrics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symbio Generrics India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Symbio Generrics India
Recent Activity within the Organization
  • Charges

    The activity A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101189362 was registered on 11 Nov 2025. was completed.

  • Charges

    A charge with Others of Rs. 35.00 Cr registered on 24 Feb 2023 with Charge ID 100683433 was modified on 06 Feb 2025. was recorded as a recent event.

  • Charges

    Progress on A charge with Others of Rs. 32.00 Cr registered on 07 Jun 2023 with Charge ID 100757679 was modified on 24 Jan 2025. was documented.

  • Annual General Meeting

    Progress on Symbio Generrics India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Charges

    A charge with Axis Bank Limited of Rs. 70.00 Cr registered on 30 Dec 2022 with Charge ID 100715443 was modified on 23 Aug 2024. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 12.00 Cr with Charge ID 100953388 was registered on 27 Jun 2024. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Symbio Generrics India Private Limited?

The CIN of Symbio Generrics India Private Limited is U74990KA2011PTC184231.

Where is Symbio Generrics India Private Limited headquartered?

Symbio Generrics India Private Limited is headquartered at Symbio House, No-1215, 24Th Main,, 11Th Cross, Hsr Layout 1St Sector,, Bangalore South, Karnataka, 560102.

When was Symbio Generrics India Private Limited incorporated?

Symbio Generrics India Private Limited was incorporated on 30 May 2011.

Who are the current directors of Symbio Generrics India Private Limited?

The current directors of Symbio Generrics India Private Limited are

What is the primary industry of Symbio Generrics India Private Limited?

The primary industry of Symbio Generrics India Private Limited is Trade.

Is Symbio Generrics India Private Limited a listed company?

Symbio Generrics India Private Limited is unlisted.

What is the capital structure of Symbio Generrics India Private Limited?

The authorized capital of Symbio Generrics India Private Limited is ₹3.10 Cr, and the paid-up capital is ₹3.01 Cr.

What is the compliance status of Symbio Generrics India Private Limited?

The compliance status of Symbio Generrics India Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available